Apr 03, 2013
Global Green’s Chief Scientist and VP – R&D to be Keynote Speaker at Texas A&M University System’s Scientific Event
TALLAHASSEE, Fla.–(BUSINESS WIRE)–Global Green, Inc. (GOGC) today announced that Konky Sotomayor, DVM, Chief Scientist and VP – R&D, has been invited to be a keynote speaker at the Texas A&M University System’s 4th Annual Practical Short Course on Trend and Development of Nutraceuticals & Functional Foods: Sources, Identification, Extraction, Separation, and Purification that will be held July 28 – 30, 2013, in College Station, Texas. This year’s Short Course will be hosted by the Food Protein R&D Center at the University.
Dr. Sotomayor is head of vaccine formulation at Global Green and is the developer of Salmogenics, the Company’s patented Salmonella vaccine for poultry. He has worked in private laboratory-managing research and development positions since 1979 including being a principal of Nutritional Health Institute Laboratories, LLC (“NHIL”). NHIL is Global Green’s research affiliate and majority shareholder. Dr. Sotomayor has extensive experience in isolation of infectious disease agents and manufacturing of the corresponding vaccines.
Established in 1939, the Food Protein Research and Development Center at Texas A&M is one of the oldest land-grant agricultural research and service programs in the nation. It specializes in process development of diverse agricultural crops and animal products into food, feed and industrial ingredients. The Center also demonstrates the feasibility of novel ingredients in various commercial food and feed applications.
About Global Green, Inc.
Global Green, Inc. is a green bio-pharmaceutical company committed to identifying technology platforms and commercializing vaccines that contain natural organisms that are not genetically modified, utilizing pharmaceutical standards without the use of mercury. For more information, visitwww.globalgreeninc.com.
This press release may contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that such forward-looking statements involve risks and uncertainties which include, among others, the inherent uncertainties associated with smaller reporting companies including, without limitation, other risks detailed from time to time in the Company’s periodic reports filed with the SEC.